United States· US:51167-290_524ddbe0-e4ac-4619-afc1-b5829bf8394c

CASGEVY

A exagamglogene autotemcel product containing exagamglogene autotemcel, registered in United States by Vertex Pharmaceuticals Incorporated. The same ATC class is registered in 12 of our 19 countries.

ATC B06AX05US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedCASGEVYATCB06AX05REGISTER NO.US:51167-290_524ddbe0…PACKS LISTED2CHECKEDJuly 12, 2026

Where it is registered

Exagamglogene autotemcel is registered in 12 of 19 countries.

Countries holding a registration under ATC B06AX05 (exagamglogene autotemcel), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 8 of them publish a price we can compare per daily dose

Exagamglogene autotemcel · ATC B06AX05

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
EXAGAMGLOGENE AUTOTEMCEL
Manufacturer
Vertex Pharmaceuticals Incorporated
Country
United States (US)
ATC code
B06AX05
ATC class
Exagamglogene autotemcel
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
July 12, 2026

Packs & prices · 2

  • ndc11
    51167-290-09
  • ndc11
    5116729009
    9 VIAL in 1 CARTON (51167-290-09) / 20 mL in 1 VIAL (51167-290-01)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1300fda0-a3ec-41c1-826e-a52dbd3265b0
GET /v1/drugs/1300fda0-a3ec-41c1-826e-a52dbd3265b0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "13000000",
  "substance": "EXAGAMGLOGENE AUTOTEMCEL",
  "productndc": "51167-290",
  "dosage_form": "INJECTION, SUSPENSION",
  "dea_schedule": null,
  "strength_unit": "1/mL",
  "application_number": "BLA125787",
  "marketing_category": "BLA"
}

See everything about exagamglogene autotemcel.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.